Florida Cancer Specialists & Research Institute

Articles

Florida Cancer Specialists & Research Institute Names Sachin Kamath, MD Compliance Committee Chairman

March 6th 2023

Florida Cancer Specialists & Research Institute has appointed Sachin Kamath, MD as Chairman of the FCS Executive Board Compliance Committee.

Florida Cancer Specialists & Research Institute Appoints Hitesh Patel, MD to Executive Board

February 20th 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.

Robert Ferdman, MD Joins Florida Cancer Specialists & Research Institute Providing Oncology Care to Clay and Duval Counties

January 23rd 2023

Florida Cancer Specialists & Research Institute, LLC welcomes Robert Ferdman, MD to the statewide practice.

Florida Cancer Specialists & Research Institute Announces Pharmacy Leadership Appointments

January 12th 2023

Long-serving pharmacy executive, Ray Bailey, retired on December 31, 2022.

Florida Cancer Specialists & Research Institute Welcomes Madhu Unnikrishnan, MD To Palm Coast Location in Flagler County

January 9th 2023

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified medical oncologist/hematologist Madhu Unnikrishnan, MD to the statewide practice.

Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies

December 23rd 2022

Florida Cancer Specialists & Research Institute, LLC takes exception to a recent study published in the New England Journal of Medicine suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.

Medical Oncologist Ke Ning, MD Joins Florida Cancer Specialists & Research Institute Sarasota Downtown Clinic

December 5th 2022

Florida Cancer Specialists & Research Institute welcomes Board-certified medical oncologist Ke Ning, MD to the Sarasota Downtown clinic team.

Florida Cancer Specialists & Research Institute Chief Medical Officer Shares Spotlight With Global Innovators in Genomic Health

October 20th 2022

Lucio Gordan, MD, chief medical officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, is a featured speaker at the Illumina Genomics Forum in San Diego.

Florida Cancer Specialists & Research Institute Breaks Ground for New Cancer Center in Wesley Chapel

October 12th 2022

Florida Cancer Specialists & Research Institute, LLC celebrated the groundbreaking for a new cancer center in Wesley Chapel at 30142 State Road 56, Wesley Chapel, Florida 33543.

Florida Cancer Specialists & Research Institute Welcomes Monique Sajjad, DO to Largo Diagnostic Clinic

September 22nd 2022

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified medical oncologist and hematologist Monique Sajjad, DO, a hospitalist with the statewide practice since 2018, is now providing care to patients at the Florida Cancer Specialists & Research Institute Largo Diagnostic Clinic, located at 1301 2nd Ave. SW, Suite 290, Largo, FL 33770.

Florida Cancer Specialists & Research Institute Celebrates Addition of Next Generation Genomic Testing Capabilities to Advance Precision Oncology Approach to Patient Care

September 20th 2022

Florida Cancer Specialists & Research Institute, LLC celebrated the addition of genomic testing capabilities at its Next Generation Sequencing laboratory in Fort Myers last week with a ribbon cutting ceremony.

Florida Cancer Specialists & Research Institute Opens Sixth Clinic Location in Pasco County

September 19th 2022

Florida Cancer Specialists & Research Institute, LLC held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.

Florida Cancer Specialists & Research Institute Welcomes Shivtaj Mann, DO, to Fort Myers Cancer Center

September 14th 2022

Florida Cancer Specialists & Research Institute welcomes Board-certified hematologist/oncologist Shivtaj Mann, DO, to the statewide practice.

Florida Cancer Specialists & Research Institute Furthers Commitment to Clinical Research and Innovation, Next-Generation Sequencing in Advancement of Cancer Care

September 6th 2022

Florida Cancer Specialists & Research Institute announced the formation of additional precision oncology capabilities and resources comprised of geneticists, informatics specialists, and database technologies that will enhance patient care through comprehensive analysis of molecular data.

Florida Cancer Specialists & Research Institute Appoints New Members to Senior Management

August 31st 2022

Florida Cancer Specialists & Research Institute is pleased to welcome Jon Meyers, Nicole Radford, FACHE, MS, MT(ASCP), Bob Simon, Paul D. Summitt, and Samantha Watkins to its senior management team.

NCODA and Florida Cancer Specialists & Research Institute Announce New Oncology Stakeholder Education Exchange Program

August 24th 2022

New cancer treatment therapies, technologies and innovations continue to be discovered and approved for use at a rapid pace, creating an education challenge for physicians and other healthcare professionals within the complex oncology landscape.

Medical Oncologist Susanna Gaikazian, MD joins Florida Cancer Specialists & Research Institute

August 9th 2022

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified medical oncologist Susanna Gaikazian, MD to the statewide practice.

Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Mariuxi Viteri Malone, MD

August 2nd 2022

Florida Cancer Specialists & Research Institute welcomes medical oncologist Mariuxi Viteri Malone, MD, to the statewide practice.

Alexander Philipovskiy MD, PhD joins Florida Cancer Specialists Drug Development Unit in Lake Mary Florida

July 18th 2022

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome Alexander Philipovskiy, MD, PhD, as a principal investigator at the Florida Cancer Specialists & Research Institute Drug Development Unit.

Florida Cancer Specialists & Research Institute Participating in Global Clinical Trial Analyzing Patient Responsiveness to Immunotherapy Treatment

July 14th 2022